Veille Scientifique

Patrice PIENKOWSKI
Coordinateur

 Après 3 ans de bons et loyaux services, la veille scientifique va s’arrêter ; voici les derniers articles sélectionnés à votre intention.
 
Nous avons pris cette décision difficile suite au constat d’un investissement très important pour un service rendu finalement incertain, comme l’attestent les statistiques de fréquentation de la rubrique sur ce site. 
 
Je remercie tous ceux et celles qui se sont investis dans la durée pour assurer la réussite du projet, à commencer par les responsables des groupes de veille : Emmanuel Coron (Endoscopie), Roger Faroux (Cancérologie), Pauline Jouët (Gastro-entérologie et proctologie), Stéphane Nahon (MICI), Vinciane Rebours (Pancréatologoie) et Christine Silvain (Hépatologie), mais aussi et surtout, tous les veilleurs anonymes pour la grande qualité de leur travail, leur compétence et leur persévérance.
Le travail de veille bibliographique ne disparait pas complètement malgré tout, grâce aux GastroScoops dont la fréquence va augmenter avec un objectif de diffusion hebdomadaire ; il s’agit d’un travail rédactionnel différent avec une analyse d’article plus approfondie et structurée, porteur de message important.

Restez donc fidèles à ces rubriques et visitez régulièrement le site de la SNFGE toujours très riche d’enseignements et d’informations.

Très cordialement.

Dr Patrice PIENKOWSKI

 

Six groupes animés par un responsable se chargent de ce travail tous les mois :

Cancers Endoscopie

Foie/
VB/
Addicto

 Gastro/
Procto/
Nutrition		 MICI Pancréas
A. LIEVRE V. VALANTIN I. ROSA P. JOUET S. NAHON V. REBOURS

V. HAUTEFEUILLE
N. WILLIET
N. FARES
Y. TOUCHEFEU

A. CULETTO
Y. LEBALEUR
G. PERROD
V. VALANTIN

C. BARRAULT
P. DUKAN
N. GANNE-CARRIE
PE. RAUTOU

H. DAMON
T. HIGUERO
V. de PARADES
F. ZERBIB

V. ABITBOL
P. FAURE
M. FUMERY
D LAHARIE
P. SEKSIK

M. CAMUS-DUBOC
E. GELSI
L. de MESTIER


Nous espérons de ce nouvel outil qu’il vous aide à accéder rapidement et sélectivement aux données nouvelles de notre discipline selon vos sujets d’intérêt, qu’ils soient larges ou très spécifiques.

Revuetrier par ordre croissant Titre Date Coup de coeur Thématique
Clinical Gastroenterology and Hepatology High Dietary Intake of Specific Fatty Acids Increases Risk of Flares in Patients With Ulcerative Colitis in Remission During Treatment With Aminosalicylates. sep. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Dietary Factors Reduce Risk of Acute Pancreatitis in a Large Multiethnic Cohort fév. 17 2 ♥ Pancréas
Clinical Gastroenterology and Hepatology Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease. juin. 16 2 ♥ MICI
Clinical Gastroenterology and Hepatology Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study oct. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Cesarean Section Delivery Is Not a Risk Factor for Development of Inflammatory Bowel Disease: A Population-based Analysis. Jan. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Association Between Ustekinumab Trough Concentrations and Clinical, Biomarker, and Endoscopic Outcomes in Patients With Crohn's Disease sep. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes. oct. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists fév. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis. avr. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Association of Vedolizumab Level, Anti-Drug Antibodies, and α4β7 Occupancy With Response in Patients With Inflammatory Bowel Disease mai. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease. juin. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis. oct. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents. Jan. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Characteristics and Progression of Preclinical Inflammatory Bowel Disease. sep. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Workplace Accommodation for Persons With IBD: What Is Needed and What Is Accessed oct. 17 2 ♥ MICI
Clinical Gastroenterology and Hepatology Low Serum Vitamin D During Remission Increases Risk of Clinical Relapse in Patients With Ulcerative Colitis fév. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases. avr. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Non-Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease. mai. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Cumulative Length of Bowel Resection in a Population-Based Cohort of Patients With Crohn's Disease oct. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota. Jan. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases juil. 16 3 ♥ MICI, Cancer colorectal (CCR)
Clinical Gastroenterology and Hepatology Biologics Delay Progression of Crohn’s Disease, but Not Early Surgery, in Children sep. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Low Rate of Dysplasia Detection in Mucosa Surrounding Dysplastic Lesions in Patients Undergoing Surveillance for Inflammatory Bowel Diseases fév. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease. mar. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Increasing Prescription of Opiates and Mortality in Patients With Inflammatory Bowel Diseases in England. mai. 18 3 ♥ MICI

Pages